#39

Precision Medicine at the Single-Cell Level

With Charlie Silver, Co-Founder and CEO of Mission Bio

Charlie is CEO and co-founder of Mission Bio where he leads a team dedicated to solving complex biological problems with precision engineering, innovative biochemistry, and supported bioinformatics. Charlie has dedicated his career to commercializing next-generation hardware technology and scientific instrumentation at emerging ventures in healthcare and semiconductor. Prior to Mission Bio, he led engineering at Novelx (acquired by Agilent) and then served in R&D and marketing at Agilent. Charlie received a joint MBA from UC Berkeley and Columbia University, an MS in physics from UW Madison, and a BA in physics from Columbia University.

Precision Medicine at the Single-Cell Level

US_UK_iTunes_Store_Get_Solid_Lockup_RGB_blk_012618.jpg

 

 

Charlie Silver, Co-Founder and CEO, Mission Bio

charlie-silver-r2.jpg

Charlie is CEO and co-founder of Mission Bio where he leads a team dedicated to solving complex biological problems with precision engineering, innovative biochemistry, and supported bioinformatics. Charlie has dedicated his career to commercializing next-generation hardware technology and scientific instrumentation at emerging ventures in healthcare and semiconductor. Prior to Mission Bio, he led engineering at Novelx (acquired by Agilent) and then served in R&D and marketing at Agilent. Charlie received a joint MBA from UC Berkeley and Columbia University, an MS in physics from UW Madison, and a BA in physics from Columbia University.